Find-Health-Articles.com - making medical research available to everyone

Ginkgo biloba (Latest Articles)

 

Latest indexed articles for 'Ginkgo biloba'

Articles 61 to 70 of 200:

To compare the efficacy and safety of nifedipine sustained release with Ginkgo biloba extract to treat patients with primary Raynaud's phenomenon in South Korea; Korean Raynaud study (KOARA study).

20 Jan 2009 This study examined the efficacy and safety of nifedipine sustained release (nifedipine SR) compared with Ginkgo biloba extract as treatment for primary Raynaud's phenomenon (RP) in Korea. Primary RP were screened and assigned to either the ...
rec_pub_19159999-to-compare-efficacy-safety-nifedipine-sustained-release-ginkgo-biloba.htm


Ginkgo biloba for cognitive impairment and dementia.

19 Jan 2009 BACKGROUND: Extracts of the leaves of the maidenhair tree, Ginkgo biloba, have long been used in China as a traditional medicine for various disorders of health. A standardized extract is widely prescribed for the treatment of a range of conditions ...
rec_pub_19160216-ginkgo-biloba-cognitive-impairment-dementia.htm


Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals.

13 Jan 2009 The chemical analysis and quality control of Ginkgo leaves, extracts, phytopharmaceuticals and some herbal supplements is comprehensively reviewed. The review is an update of a similar, earlier review in this journal [T.A. van Beek, J. Chromatogr. A ...
rec_pub_19195661-chemical-analysis-quality-control-ginkgo-biloba-leaves-extracts.htm


[The phenomenon of different study results. Were the research participants too old?]

13 Jan 2009
rec_pub_19227629-the-phenomenon-different-study-results-research-participants-old.htm


Inhibitions of vascular endothelial growth factor expression and foam cell formation by EGb 761, a special extract of Ginkgo biloba, in oxidatively modified low-density lipoprotein-induced human THP-1 monocytes cells.

6 Jan 2009 It has been reported that oxidatively modified low-density lipoprotein (Ox-LDL) involvement with vascular endothelial growth factor (VEGF) and foam cell formation play an important role in atherosclerosis (AS). Protective effects of Ginkgo biloba ...
rec_pub_19135347-inhibitions-vascular-endothelial-growth-factor-expression-foam-cell.htm


Extract of Ginkgo biloba induces glutathione-S-transferase subunit-P1 in vitro.

5 Jan 2009 The extract of Ginkgo biloba (EGb), containing 24% flavone glycosides and 6% terpenoids, is widely used to treat early-stage Alzheimer's disease, vascular dementia, peripheral claudication and vascular tinnitus. Its remarkable antioxidant activity ...
rec_pub_19131229-extract-ginkgo-biloba-induces-glutathione-s-transferase-subunit-p1.htm


Analysis of trace elements in Chinese therapeutic foods and herbs.

30 Dec 2008 The bioactive elements in Chinese therapeutic foods and herbs that are frequently consumed by people in both the East and West are analyzed. These elements in their appropriate dosage range are considered to be beneficial to health. Inductively ...
rec_pub_19655402-analysis-trace-elements-chinese-therapeutic-foods-herbs.htm


Gingko biloba Extract (EGb 761) prevents ischemic brain injury by activation of the Akt signaling pathway.

30 Dec 2008 EGb 761 is a standardized extract of Gingko biloba that exerts protective effects against ischemic brain injury. This study investigated whether EGb 761 modulates the neuroprotective effects through Akt and its downstream targets, Bad and FKHR. ...
rec_pub_19606514-gingko-biloba-extract-egb-761-prevents-ischemic-brain-injury.htm


[Experimental study on effect of total flavone of Ginkgo biloba on delaying cell senescence]

30 Dec 2008 OBJECTIVE: To investigate the mechanism of delaying the senescence of human diploid fibroblast (2BS) by total flavone of Ginkgo biloba (FG). METHODS: The drug sera of FG was used to treat the 2BS. The population doublings of 2BS cells were observed, ...
rec_pub_19445133-experimental-study-effect-total-flavone-ginkgo-biloba-delaying-cell.htm


[Ginkgo biloba extracts (EGb761) inhibits aflatoxin B1-induced hepatocarcinogenesis in Wistar rats]

30 Dec 2008 OBJECTIVE: To investigate the effect of Ginkgo biloba extracts (EGb761) on aflatoxin B1 (AFB1)-induced hepatocarcinogenesis and its antioxidant activity in Wistar rats. METHODS: 71 Wistar rats were randomly divided into three groups: AFB1 (group A); ...
rec_pub_19445131-ginkgo-biloba-extracts-egb761-inhibits-aflatoxin-b1-induced.htm

Results: [1-10] [11-20] [21-30] [31-40] [41-50] [51-60] [61-70] [71-80] [81-90] [91-100] [101-110] [111-120] [121-130] [131-140] [141-150] [151-160] [161-170] [171-180] [181-190] [191-200]

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index